Clinical Trial Update: Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating hyperbaric oxygen therapy for Pyoderma gangrenosum has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma Gangrenosum

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: Erasmus Medical Center | Conditions: Pyoderma Gangrenosum | Phase 3 | Status: TERMINATED